Understanding of cellular transdifferentiation is limited by the technical inability to track multiple lineages in vivo. To overcome this we developed a new tool to simultaneously fate map two distinct cell types in the kidney, and genetically test whether cells of renin lineage (CoRL) can transdifferentiate to a podocyte fate. Ren1cCreER/ tdTomato/Nphs1-FLPo/FRT-EGFP mice (CoRL-PODO mice) were generated by crossing Ren1c-CreER/tdTomato CoRL reporter mice with Nphs1-FLPo/FRT-EGFP podocyte reporter mice. Following tamoxifen administration in these animals, CoRL were labeled with red fluorescence (tdTomato) and co-localized with renin. Podocytes were labeled green (enhanced green fluorescent protein) and co-localized with nephrin. Following podocyte loss by nephrotoxic antibody and subsequent enalapril-enhanced partial replacement, tdTomato-EGFP-labeled CoRL were detected as yellowcolored cells in a subset of glomerular tufts, without the use of antibodies. Co-localization with podocin indicated that these cells are podocytes, derived from CoRL origin. Thus, our novel study shows that two distinct cell types can be simultaneously labeled in the mouse kidney and provide strong genetic evidence in vivo that lost podocytes can be replaced in part by CoRL.
S
ite-specific recombinase (SSR) is an essential tool for lineage-tracing cells in mice. 1 DNA recombinases from the P1 bacteriophage (Cre) and Saccharomyces cerevisiae (flippase, FLP), combined with cell-specific promoters and reporters silenced by loxP-or FRT-flanked STOP sequences, allow for permanent expression of either fluorescent or enzymatic reporters in specific cell populations. 2 Combined with ligand-dependent activation, such as the tamoxifenresponsive CreER T2 recombinase, SSR can be achieved within specific temporal periods. 3, 4 This provides a noninvasive method of mapping cell fate throughout development or tracing cell lineages during disease and/or regeneration.
SSR techniques have been used extensively in the study of kidney regeneration, and have led to several significant findings regarding the ability of distinct cell populations to undergo repair. 4 Yet, despite these genetic advances, simultaneous lineage tracing of 2 distinct cell types has been a challenge, in part because the majority of SSR in the kidney utilizes only Cre-loxP recombination. 5, 6 Expression of Cre recombinase, even under the control of distinct promoters and utilizing distinct reporters, cannot uniquely label 2 cell types. This has posed a barrier in our ability to observe transdifferentiation events, in which 1 cell type adopts the characteristics of another. The limited numbers of studies that have been performed that utilize Cre and FLP systems simultaneously, outside of the kidney, are intersectional or subtractive genetic fate mapping that do not allow for the continuous tracing of 2 distinct populations and require enzymatic or immunohistochemical staining of the b-gal reporter. 1, 7 Here, we have succeeded in simultaneously labeling 2 distinct kidney cell populations by combining Cre-lox and FLP-FRT recombination strategies in the same mouse, regardless of sex, with the use of directly observable fluorescent reporters that we are calling dual lineage tracing. We utilized this methodology to genetically demonstrate that cells of renin lineage (CoRL) transdifferentiate toward a podocyte fate following podocyte depletion. Figure 1 shows a schema of our dual transgenic approach. Unlabeled CoRL activate the Ren1c promoter inducing CreER expression; however, CreER remains sequestered in the cytoplasm and unable to bind loxP (Figure 1a   1 ). Following tamoxifen, CreER translocates to the nucleus and recombines the loxP sites to remove the STOP cassette, thus inducing permanent tdTomato expression (Figure 1a 2 ). As podocytes mature (Figure 1b ). Figure 2 shows validation of our dual lineage tracing approach. Following tamoxifen, young adult Ren1cCreER/ tdTomato/Nphs1-FLPo/FRT-EGFP mice (herein called CoRL-PODO mice) expressed tdTomato specifically in cells in the juxta-glomerular compartment (JGC) (Figure 2a, arrow) . As shown previously, tdTomato overlapped with 95% of renin þ cells (Figure 2b, arrow) . When CoRL-PODO mice were given the tamoxifen vehicle corn oil, tdTomato was not detected in the JGC (Figure 2c, arrow) . Similarly, in mice lacking the Ren1cCreER transgene, tdTomato was not detected following tamoxifen administration (Figure 2d , arrow).
RESULTS
In the same mouse, EGFP (green) was detected within the glomerular tuft in a podocyte distribution pattern ( Figure 2a ) and overlapped with staining for the podocyte marker nephrin in 98% of EGFP þ cells (Figure 2e , arrow). However, in CoRL-PODO mice lacking the Nphs1-FLPo transgene, EGFP was not detected (Figure 2f, arrow) . There was no overlap between tdTomato and EGFP under normal nonstressed conditions (Figure 2a ). These results show distinct inducible tdTomato labeling of CoRL in the JGC and constitutive EGFP labeling of podocytes in the glomerular tuft, in the same kidney. As this approach enabled simultaneous tracking of 2 cell types in vivo, we called it dual lineage tracing.
To genetically demonstrate that a subset of CoRL can replace lost podocytes in disease, experimental focal segmental glomerulosclerosis (FSGS), characterized by podocyte loss and subsequent partial replacement, was induced in CoRL-PODO mice with a nephrotoxic antibody. 8, 9 Mice were treated with enalapril, which we have previously shown increases podocyte repletion. 8, 9 Dual lineage tracing was performed to follow migration and transdifferentiation (Figure 3) . At baseline, ) Upon transdifferentiation to a podocyte fate, the Nphs1 promoter is activated (black box, white type), driving FLPase (black flag, white type) expression; FLPase recombines the FRT sites (blue chevron, black type) and STOP cassette (white box, black type), inducing permanent enhanced green fluorescent protein (green box, black type), resulting in a yellow color. , and merged fluorescence channels, respectively. It should be noted that the tdTomato and EGFP reporters are not targeted to any particular cellular compartment, whereas staining for native proteins such as podocin are localized to specific structures, such as the slit diaphragms of foot processes in normal podocytes. 24 Furthermore, not all tdTomato þ CoRL that migrate onto the tuft (arrowheads) express podocyte markers.
to induce permanent labeling of CoRL with tdTomato using the Ren1c promoter and constitutively and permanently label podocytes with EGFP using the Nphs1 promoter. The 2 reporters did not overlap under normal (no disease) conditions. These results support that dual lineage tracing is feasible in the kidney. The possibility of any off-target effects of Cre expression is highly unlikely given the extended washout period used in the current studies.
A similar dual SSR approach utilized dual loxP-flanked STOP and FRT-flanked STOP cassettes upstream of the EGFP gene. After removal of the flanked STOP cassettes via Creand FLPo-mediated recombination, EGFP reporter was expressed. 12 This system utilized 2 unique promoter-driven SSR systems, but labeled the cell of interest with EGFP only when both promoters were active. Therefore, it did not label 2 distinct cell types with 2 distinct reporters.
The second finding was genetic evidence that a subset of lineage traced CoRL transdifferentiate toward an adult podocyte fate following podocyte depletion in experimental FSGS. Previously, our group 11, 13, 14 and others 15, 16 have relied on the de novo coexpression of cell-specific markers in reporterlabeled cells as evidence of transdifferentiation. For example, labeled CoRL coexpressing podocin suggests a podocyte fate, claudin-1 a parietal epithelial cell fate, a8 integrin a mesangial cell fate, and PDGFß-receptor/NG2 a pericyte fate. 11, [13] [14] [15] [16] Here we show tdTomato þ CoRL track into the glomerulus following podocyte depletion, and express EGFP under the control of nephrin promoter activity, a podocyte-specific gene. These findings are consistent with genetic evidence of CoRL transdifferentiation toward a podocyte fate. Furthermore, de novo coexpression of podocyte-specific markers were observed in dual reporter þ CoRL. We acknowledge that there is some debate regarding the replenishment of adult podocytes following disease-induced loss. Elegant studies by Wanner et al. used a diphtheria toxin podocyte injury model and showed a 38% renewal of ablated podocytes in that model. 17 In the adriamycin nephropathy model of podocyte injury, Lasagni et al. showed a 5% to 10% regeneration of podocyte by renal progenitor cells. 15 Our data showed that in a subset of individual glomeruli with reduced podocyte density, yellow cells were detected, which in the current study are the genetic readout for CoRL transdifferentiating into podocytes. While CoRL themselves are clearly not adequate to fully replace podocytes, together with other progenitor sources they may be able to tip the balance enough to reduce scarring and improve proteinuria, as demonstrated in these studies. In addition to the current model, we have demonstrated CoRL migration into the glomerulus following chronic podocyte depletion in the experimental remnant kidney model. 14 We considered using the mTmG system, which also utilizes dual reporters, where membrane-targeted tandem dimer Tomato (mT) is expressed ubiquitously prior to Cremediated excision and membrane-targeted green fluorescent protein (mG) after excision. Such dual reporters allow for genetic evidence of transdifferentiation but do not allow for active dual lineage tracing. 18, 19 We recognize that a limitation to the current study is the use of constitutive podocyte labeling rather than inducible labeling. To our knowledge, ligand-inducible FLP-FRT systems are limited at this time. Furthermore, the constitutive FLP-FRT system in this study proved helpful, as we were able to show strong genetic evidence of CoRL transdifferentiation to podocytes without requiring the continuous presence of ligand during the 28 days of study. Taken together, these are not a major weakness to the current study.
Others have shown that the use of 4-mm sections, particularly when observing glomeruli, is problematic due the relatively small sampling of the y80-mm glomerulus (4 mm ¼ 5%) and the inherent heterogeneity in glomerular size both normally and in disease. 20 In the current study, we utilized 20-mm sections and optical sectioning by confocal microscopy. We noted a marked increase in the ability to detect reporter þ CoRL compared to a single 4-mm section. We therefore recommend that lineage tracing in glomerular studies be performed by optically sectioning thick sections or utilizing multiple physical thin sections.
In conclusion, we have successfully shown the effective use of dual lineage tracing in the kidney, which enables tracking 2 different cell types in vivo. We have furthermore utilized dual lineage tracing to demonstrate the transdifferentiation of a subset of CoRL into podocytes in the kidney glomerulus after injury. As dual lineage tracing is highly flexible and could be used for a variety of different promoters and genes, it provides a powerful new tool to monitor the cellular changes and transitions during homeostasis and regeneration.
METHODS Animals
Dual reporting Ren1cCreER/tdTomato/Nphs1-FLPo/FRT-EGFP (CoRL-PODO) were bred by crossing our previously generated inducible Ren1cCreER/tdTomato mice, utilizing the tdTomato clone Ai14 (Jackson Laboratory stock no. 007914) 21, 22 with Nphs1-FLPo/ FRT-EGFP mice. The Nphs1-FLPo mouse expresses an optimized FLP recombinase (FLPo) under the control of a 4.2-kb fragment of the mouse nephrin promoter and has been characterized and previously described by Goldberg et al. 23 The FRT-EGFP mice, also known as RCE:FRT (stock no. 010812), were purchased from the Jackson Laboratory (Bar Harbor, ME). In Nphs1-FLPo/FRT-EGFP mice, the FRTflanked STOP cassette is excised, allowing for specific and permanent EGFP reporter expression in podocytes. Control mice comprised triple transgenic mice without the Cre or FLP. Both male and female mice were utilized, and no differences between sexes were observed in these studies. Mice were housed in the animal care facility of the University of Washington under specific pathogen-free conditions. Studies were reviewed and approved by the University of Washington Institutional Animal Care and Use Committee (2968-04).
Reporter induction
Permanent labeling of CoRL with td-Tomato was induced in young adult (8-week-old) male and female CoRL-PODO mice by delivering 100 mg/ kg tamoxifen (Sigma-Aldrich, St. Louis, MO), in corn oil (SigmaAldrich), 4 times i.p. every other day. This was followed by a washout period of 4 weeks. Control for tamoxifen was vehicle (corn oil) alone. No drugs were required for the induction of the EGFP reporter. 
Podocyte depletion
Experimental FSGS was induced in CoRL-PODO mice by 2 i.p. injections, 24 hours apart, of sheep anti-glomerular antibody at 12 mg/ 20 g body weight.
9,11,14 Animals were given enalapril (75 mg/l drinking water, Sigma-Aldrich) starting on day 3 of FSGS through day 28 to augment podocyte regeneration. 9 Tissue collection Mice were killed with an overdose of ketamine and xylazine, cardiac perfused with 10 to 15 ml of ice-cold phosphate-buffered saline (PBS) at 25 inches of gravity pressure through a 21-gauge butterfly infusion set. Kidneys were removed when blanched and split lengthwise or "butterflied." Kidneys were then placed into 4% paraformaldehyde in PBS (PFA; Affymetrix, Santa Clara, CA) for 45 minutes, washed briefly in PBS, placed in 30% sucrose in PBS (Sigma-Aldrich) overnight, blotted dry, embedded in Tissue-Tek O.C.T. Compound (VWR, Radnor, PA), and frozen in a 100% ethanol and dry ice bath.
Visualization of dual (tdTomato/EGFP) reporter
In order to visualize tdTomato and EGFP, 20-mm cryosections were rinsed in PBS (pH 7.4) to remove OCT compound and mounted with Vectashield with DAPI (Vector Labs, Burlingame, CA). No antibodies were required for visualization of the dual tdTomato and EGFP reporters. Confocal images were acquired with a Leica TCS SPE II laser scanning confocal microscope (Solms, Germany) with Â40 (1.3 NA) oil objective, at 1024 Â 1024 pixel format with 12-bit intensity resolution. Sets of 50 serial images were collected at 0.4-mm step size. The acquisition wavelengths were set as follows: EGFP 488 nm excitation and 497 to 510 nm emission, and tdTomato 561 nm excitation and 575 to 654 nm emission.
Multicolor immunofluorescence staining
Indirect immunofluorescence staining was performed on 20-mm sections from 4% PFA-fixed frozen tissue processed as described above, and as previously performed. 11, 14 Frozen sections were warmed from -80 o C to room temperature and allowed to air-dry. All sections were equilibrated in PBS (pH 7.4) then blocked with Background Buster (Accurate Chemical & Scientific Corporation, Westbury, NY) for 30 minutes to minimize nonspecific protein interactions. Endogenous biotin activity was quenched with the avidin and biotin blocking kit (Vector Laboratories). After blocking, sections were incubated overnight at 4 C with the appropriate primary antibodies: to identify podocytes, guinea pig antibody to nephrin, dilution 1:500 (Fitzgerald Industries International. Inc., 20R-NP002, Concord, MA), and rabbit antibody to podocin, dilution 1:4000 (Abcam, ab 50339, Cambridge, MA), were used. The appropriate biotinylated secondary antibodies (Vector Laboratories) were applied and followed by StreptavidinAlexaFluor 647 (Life Technologies -Molecular Probes, Grand Island, NY). To demarcate the glomerular compartment, biotinylated collagen IV antibody, dilution 1:100 (Southern Biotechnology, 1340-08, Birmingham, AL) and StreptavidinAlexaFluor 647 (Life Technologies) were used. Biotinylated antirenin antibody, dilution 1:100 (Innovative Research, IASMPREN-GF-HT-BIO, Novi, MI) and Streptavidin-AlexaFluor 647 were used to detect renin. All immunofluorescence samples were mounted using Vectashield with DAPI. As a negative control, all staining was performed without primary antibodies.
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